🔎 Trials Near Me

Home › Soft Tissue Sarcoma › NCT06905132

Preoperative 5-Day Radiotherapy for Soft Tissue Sarcoma

RecruitingPhase 2

Preoperative 5-Day Radiotherapy for Soft Tissue Sarcoma: A Single Institution Phase II Trial

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* Willingness and provision of informed consent via signed and dated copy.
* Histologically confirmed STS of extremity or trunk.
* Male or female, aged greater than or equal to 18 years old
* ECOG performance status 0-3
* Meets screening criteria for receipt of radiotherapy.
* Deemed eligible for wide local excision.
* Patient and/or physician identified possible barriers to receiving a 5-week course of conventionally fractionated preoperative radiotherapy. Potential barriers include but are not limited to concern for local progression that could precluded or complicate limb sparing surgery, concern for distant progression that could result in patient being non-operative, financial and/or physical burden of travel for daily treatments, financial burden of time away from work or caregiving.

Exclusion Criteria:

* Distant metastatic disease
* Prior radiation therapy in the proposed treatment area
* Simultaneous treatment of another malignancy
* Women who are pregnant or plan to become pregnant during the period of radiation therapy
* Planned concurrent administration of chemotherapy and radiation therapy

About the study

The purpose of this research study is to preserve healthy tissue around the cancer on the arm(s) and/or leg(s) using Hypofractionated radiotherapy, while treating the cancer and preventing it from spreading to other areas of the body.

What is being tested

Sponsor: Medical University of South Carolina · Participants: 40 · Started: Apr 1, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT06905132

Locations in the U.S.

South CarolinaMedical University of South Carolina, Charleston

Conditions

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.